ID.1
Item
males and females, 18 to 77 years old, with type 2 diabetes and inadequate glycemic control
boolean
C0001779 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
ID.2
Item
participants who have been receiving metformin at a total daily dose ≥1500 mg per day for at least 8 weeks
boolean
C0025598 (UMLS CUI [1])
ID.3
Item
c-peptide ≥1.0 ng/ml
boolean
C0202100 (UMLS CUI [1])
ID.4
Item
body mass index ≤45.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
ID.5
Item
serum creatinine level <1.50 mg/dl for men or <1.40 mg/dl for women.
boolean
C0600061 (UMLS CUI [1])
ID.7
Item
aspartate aminotransferase and/or alanine aminotransferase level >3.0 times the upper limit of normal
boolean
C0004002 (UMLS CUI [1,1])
C0001899 (UMLS CUI [1,2])
ID.8
Item
serum total bilirubin level >2 mg/dl
boolean
C1278039 (UMLS CUI [1])
ID.9
Item
creatinine kinase level >3 times upper limit of normal
boolean
C1657311 (UMLS CUI [1])
ID.10
Item
symptoms of severely uncontrolled diabetes
boolean
C0810250 (UMLS CUI [1])
ID.11
Item
serum creatinine level 1.50 mg/dl for men or 1.40 mg/dl for women
boolean
C0600061 (UMLS CUI [1])
ID.12
Item
currently unstable or serious cardiovascular, renal, hepatic, hematologic, oncologic, endocrine, psychiatric, or rheumatic diseases
boolean
C0443343 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])